Project REMOTE (REimagining Measurements and Operations of Translational Endpoints)
Public ClinicalTrials.gov record NCT06776367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Longitudinal Assessment of Potential Immunologic Correlates of Risk and Protection Following COVID-19 Vaccination Comparing Remote and Site-based Specimen Collection (Feasibility, Validity, and Proof of Concept)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is designed to assess immunological biomarkers measured from blood samples that can be used to reliably predict how well vaccines work against symptomatic COVID-19 as well as to evaluate the feasibility of remote, self-collected specimens when conducting a correlates analysis. For a lot of research studies, people need to go to the study doctor's office regularly. For this study, we want to see if it is okay that people do the study doctor visits virtually, fill out questionnaires electronically, and collect their own samples remotely. Participants will enroll in the study after receiving a COVID-19 vaccine in their community, and saliva and blood specimens will be collected at pre-defined time-points over a 12-month period. Additionally, participants will report weekly whether they experience symptoms of COVID-19, and if so, will be prompted to collect a nasal swab for testing. Most participants will complete all activities remotely and via electronic communications, but a small number will complete activities in person at the doctor's office to provide a comparison group. Samples from the study will be analyzed to determine whether the biomarkers can be measured, and data from the study will be used to evaluate the feasibility of doing the specimen and data collection without the participant going to the doctor's office in person.
Study identification
- NCT ID
- NCT06776367
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,753 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2024
- Primary completion
- Aug 18, 2026
- Completion
- Aug 18, 2026
- Last update posted
- Sep 2, 2026
2024 – 2026
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Accel Research Site Networks - Birmingham CRU / Elite | Vestavia Hills | Alabama | 35216 | — |
| Desert Clinical Research | Mesa | Arizona | 85213 | — |
| Apex Research Group | Fair Oaks | California | 95628 | — |
| Wake Research Encino | Los Angeles | California | 91316 | — |
| Wake Research San Diego | San Diego | California | 92111 | — |
| Research Institute of South Florida | Miami | Florida | 33173 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Wake Research Atlanta | Atlanta | Georgia | 30328 | — |
| Johnson County Clinical Trials (JCCT) | Lenexa | Kansas | 66219 | — |
| Research Integrity / WCG | Owensboro | Kentucky | 42303 | — |
| Alcanza / hyperCORE | Boston | Massachusetts | 02131 | — |
| Be Well Clinical Studies / Elite | Lincoln | Nebraska | 68516 | — |
| SUNY / Upstate Medical University Global Health Institute | Syracuse | New York | 13057 | — |
| Kroger The Little Clinic (Remote Site) | Blue Ash | Ohio | 45242 | — |
| Lynn Health Science Institute East / Elite | Oklahoma City | Oklahoma | 73112 | — |
| Wake Research Dallas | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06776367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06776367 live on ClinicalTrials.gov.